Cover Image
市場調查報告書

非專利注射劑的全球市場:產業趨勢,佔有率,市場規模,成長率,市場機會,預測

Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

出版商 IMARC Services Pvt. Ltd. 商品編碼 547086
出版日期 內容資訊 英文 95 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
非專利注射劑的全球市場:產業趨勢,佔有率,市場規模,成長率,市場機會,預測 Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022
出版日期: 2017年08月11日 內容資訊: 英文 95 Pages
簡介

本報告提供非專利注射劑的全球市場調查,整體市場趨勢,各治療領域、流通管道、地區的詳細趨勢,相關市場概要,競爭情形,製造工程和計劃的經濟性等總括性彙整。

第1章 序文

第2章 調查範圍、調查手法

第3章 摘要整理

第4章 簡介

  • 市場概要
  • 主要產業趨勢

第5章 學名藥的全球市場

  • 市場概要
  • 市場成果
  • 市場明細:各地區
  • 市場預測
  • 主要企業

第6章 非專利藥物輸送的全球市場

  • 口服劑
  • 注射劑
  • 經皮給藥劑
  • 吸入劑

第7章 非專利注射劑的全球市場

  • 市場概要
  • 市場成果
  • 市場明細:各地區
  • 市場明細:各治療領域
  • 市場明細:各流通管道
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特的五力分析

第8章 非專利注射劑的全球市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第9章 市場分析:各治療領域

  • 癌症
  • 麻醉
  • 抗感染疾病藥
  • 高卡路里輸液
  • 心血管

第10章 市場分析:各流通管道

  • 醫院
  • 零售藥局

第11章 競爭情形

  • 競爭結構
  • 主要企業

第12章 非專利注射劑的製造工程

  • 產品概要
  • 詳細的流程
  • 單位操作的種類
  • 物質收支、原料的要求

第13章 計劃詳細內容、要求、經費

  • 土地
  • 建設
  • 工廠
  • 機器
  • 原料
  • 包裝
  • 物流
  • 公共事業
  • 人力資源
  • 其他資本設備

第14章 貸款、資金援助

第15章 計劃的經濟性

  • 計劃的資本成本
  • 技術、經濟參數
  • 產品價格
  • 稅金、折舊費
  • 收入預測
  • 支出預測
  • 財務分析
  • 收益分析
目錄
Product Code: SR0617A3

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to IMARC Group's latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global generic injectables market reached a value of more than US$ 23 Billion in 2016, exhibiting a CAGR of around 9% during 2009-2016.

The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the total market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the total global share. The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.

This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

Key Questions Answered in This Report:

  • How has the generic injectables market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic injectables industry?
  • What are the price trends of generic injectables?
  • What are the various stages in the value chain of the generic injectables industry?
  • What are the key driving factors and challenges in the generic injectables industry?
  • What is the structure of the global generic injectables industry and who are the key players?
  • What is the degree of competition in the global generic injectables industry?
  • What are the profit margins in the generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
  • What are the operating costs for setting up a generic injectables manufacturing plant?
  • What will be the income and expenditures for a generic injectables manufacturing plant?
  • What is the time required to break-even?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Generic Drug Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Region
  • 5.4. Market Forecast
  • 5.5. Major Players

6. Global Generic Drug Delivery Market

  • 6.1. Oral
  • 6.2. Injectables
  • 6.3. Dermal/Topical
  • 6.4. Inhalers

7. Global Generic Injectables Market

  • 7.1. Market Overview
  • 7.2. Market Performance
  • 7.3. Market Breakup by Region
  • 7.4. Market Breakup by Therapeutic Area
  • 7.5. Market Breakup by Distribution Channel
  • 7.6. Market Forecast
  • 7.7. SWOT Analysis
  • 7.7.1. Strengths
  • 7.7.2. Weaknesses
  • 7.7.3. Opportunities
  • 7.7.4. Threats
  • 7.8. Value Chain Analysis
  • 7.9. Porter's Five Forces Analysis
    • 7.9.1. Overview
    • 7.9.2. Bargaining Power of Buyers
    • 7.9.3. Bargaining Power of Suppliers
    • 7.9.4. Degree of Competition
    • 7.9.5. Threat of New Entrants
    • 7.9.6. Threat of Substitutes
  • 7.10. Key Market Drivers and Success Factors

8. Global Generic Injectables Market: Performance of Key Regions

  • 8.1. North America
  • 8.2. Europe
  • 8.3. Asia
  • 8.4. Latin America
  • 8.5. Middle East and Africa

9. Market by Therapeutic Area

  • 9.1. Oncology
  • 9.2. Anaesthesia
  • 9.3. Anti-infectives
  • 9.4. Parenteral Nutrition
  • 9.5. Cardiovascular

10. Market by Distribution Channel

  • 10.1. Hospitals
  • 10.2. Retail Pharmacy Stores

11. Global Generic Injectable Market: Competitive Landscape

  • 11.1. Competitive Structure
  • 11.2. Market Breakup by Key Players

12. Generic Injectable Manufacturing Process

  • 12.1. Product Overview
  • 12.2. Detailed Process Flow (Injectable)
  • 12.3. Various Types of Unit Operations Involved
  • 12.4. Mass Balance and Raw Material Requirements

13. Project Details, Requirements and Costs Involved

  • 13.1. Land Requirements and Expenditures
  • 13.2. Construction Requirements and Expenditures
  • 13.3. Plant Machinery
  • 13.4. Machinery Pictures
  • 13.5. Raw Material Requirements and Expenditures
  • 13.6. Packaging Requirements and Expenditures
  • 13.7. Transportation Requirements and Expenditures
  • 13.8. Utility Requirements and Expenditures
  • 13.9. Manpower Requirements and Expenditures
  • 13.10. Other Capital Investments

14. Loans and Financial Assistance

15. Project Economics

  • 15.1. Capital Cost of the Project
  • 15.2. Techno-Economic Parameters
  • 15.3. Product Pricing and Margins Across Various Levels of the Supply Chain
  • 15.4. Taxation and Depreciation
  • 15.5. Income Projections
  • 15.6. Expenditure Projections
  • 15.7. Financial Analysis
  • 15.8. Profit Analysis

16. Key Player Profiles

  • 16.1. Hospira (Pfizer)
    • 16.1.1. Company Overview
    • 16.1.2. Product Portfolio
    • 16.1.3. Financials
    • 16.1.4. SWOT Analysis
  • 16.2. Fresenius Kabi
    • 16.2.1. Company Overview
    • 16.2.2. Product Portfolio
    • 16.2.3. Financials
    • 16.2.4. SWOT Analysis
  • 16.3. Hikma
    • 16.3.1. Company Overview
    • 16.3.2. Product Portfolio
    • 16.3.3. Financials
    • 16.3.4. SWOT Analysis
  • 16.4. Sandoz (Novartis)
    • 16.4.1. Company Overview
    • 16.4.2. Product Portfolio
    • 16.4.3. Financials
    • 16.4.4. SWOT Analysis
  • 16.5. Sagent
    • 16.5.1Company Overview
    • 16.5.2. Product Portfolio
    • 16.5.3. Financials
    • 16.5.4. SWOT Analysis
  • 16.6. Sanofi
    • 16.6.1. Company Overview
    • 16.6.2. Product Portfolio
    • 16.6.3. Financials
    • 16.6.4. SWOT Analysis
  • 16.7. Baxter
    • 16.7.1. Company Overview
    • 16.7.2. Product Portfolio
    • 16.7.3. Financials
    • 16.7.4. SWOT Analysis

List of Figures

  • Figure 1: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2010 - 2016
  • Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2016
  • Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 - 2022
  • Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2009, 2016 & 2022
  • Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2009,2 016 & 2022
  • Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2009, 2016 & 2022
  • Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2009, 2016 & 2022
  • Figure 8: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2009 - 2016
  • Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2016
  • Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2016
  • Figure 11: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2016
  • Figure 12: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2017 - 2022
  • Figure 13: Global: Generic Injectables Industry: SWOT Analysis
  • Figure 14: Global: Generic Injectables Industry: Value Chain Analysis
  • Figure 15: Global: Generic Injectables Industry: Porter's Five Forces Analysis
  • Figure 16: North America: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 17: Europe: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 18: Asia: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 19: Latin America: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 20: Middle East and Africa: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 21: Oncology: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 22: Anaesthesia: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 23: Anti-infectives: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 24: Parenteral Nutrition: Generic Injectable Market (in Billion US$), 2009, 2016 & 2022
  • Figure 25: Cardiovascular: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
  • Figure 26: Hospitals: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
  • Figure 27: Retail Pharmacy Stores: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
  • Figure 28: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 29: Generic Injectable Manufacturing Plant: Detailed Process Flow
  • Figure 30: Generic Injectable Manufacturing: Production Cost Breakup (in %)
  • Figure 31: Generic Injectable Industry: Profit Margins at Various Levels of the Supply Chain
  • Figure 32: Generic Injectable Manufacturing Plant: Proposed Plant Layout
  • Figure 33: Generic Injectable Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

  • Table 1: Global: Generic Drug Market: Key Industry Highlights, 2016 and 2022
  • Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2017-2022
  • Table 3: Global: Generic Drug Market: Revenues of Key Players (in US$ Billion), 2016
  • Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2016 and 2022
  • Table 5: Global: Generic Injectables Market Forecast: Breakup by Region, 2017-2022
  • Table 6: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 7: Generic Injectable Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 8: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit (in US$)
  • Table 9: Generic Injectable Manufacturing Plant: Raw Material Requirements
  • Table 10: Generic Injectable Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 11: Generic Injectable Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
  • Table 12: Details of Financial Assistance Offered by Financial Institutions
  • Table 13: Generic Injectable Manufacturing Plant: Capital Costs (in US$)
  • Table 14: Generic Injectable Manufacturing Plant: Techno-Economic Parameters
  • Table 15: Generic Injectable Manufacturing Plant: Taxation and Depreciation (in US$)
  • Table 16: Generic Injectable Manufacturing Plant: Income Projections (in US$)
  • Table 17: Generic Injectable Manufacturing Plant: Expenditure Projections (in US$)
  • Table 18: Generic Injectable Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
  • Table 19: Generic Injectable Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
  • Table 20: Generic Injectable Manufacturing Plant: Profit and Loss Account
Back to Top